These sources explain the U.S. "Right to Try" legislation and its implications for the Korean healthcare system. The law aims to uphold patient autonomy and the dignity of life by allowing terminally ill patients to attempt experimental treatments that have not yet received full regulatory approval. The articles emphasize the need for ethical and institutional discussions on protecting patient choice in the era of precision medicine, as technological advancements continue. They argue that Korea should also move beyond the right to treatment and establish a legal framework recognizing the right to try. Overall, these writings highlight the importance of a healthcare system that empowers patients to make proactive choices—even in the final moments of life.

Ver todos los episodios